Medicare slashes payment for BRCA testBMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f7709 (Published 31 December 2013) Cite this as: BMJ 2013;347:f7709
- Michael McCarthy
Medicare, the US health insurance plan for elderly and disabled people, will halve its maximum reimbursement for the BRCA1 and BRCA2 breast cancer gene tests to $1440, down from the maximum of $2795 it paid in 2013, the US Centers for Medicare and Medicaid Services …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial